These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1624375)

  • 1. Syntheses and activities of some bactobolin derivatives.
    Nishimura Y; Kondo S; Takeuchi T
    J Antibiot (Tokyo); 1992 May; 45(5):735-41. PubMed ID: 1624375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some structure-activity relationships for bactobolin analogs in the treatment of mouse leukemia P388.
    Munakata T; Okumoto T
    Chem Pharm Bull (Tokyo); 1981 Mar; 29(3):891-4. PubMed ID: 7249163
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and activities of bactobolin derivatives based on the alteration of the functionality at C-3 position.
    Adachi H; Usui T; Nishimura Y; Kondo S; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1998 Feb; 51(2):184-8. PubMed ID: 9544940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinone modified derivatives of cyanonaphthyridinomycin.
    Zmijewski MJ; Mikolajczak MJ
    J Antibiot (Tokyo); 1983 Dec; 36(12):1767-9. PubMed ID: 6662817
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and activities of bactobolin derivatives having new functionality at C-3.
    Adachi H; Nishimura Y; Takeuchi T
    J Antibiot (Tokyo); 2002 Jan; 55(1):92-8. PubMed ID: 11918072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 2''-amino-2''-deoxyarbekacin and its analogs having potent activity against methicillin-resistant Staphylococcus aureus.
    Kondo S; Ikeda Y; Ikeda D; Takeuchi T; Usui T; Ishii M; Kudo T; Gomi S; Shibahara S
    J Antibiot (Tokyo); 1994 Jul; 47(7):821-32. PubMed ID: 8071128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of cholic acid-derived antimicrobial agents against multidrug-resistant bacteria.
    Schmidt EJ; Boswell JS; Walsh JP; Schellenberg MM; Winter TW; Li C; Allman GW; Savage PB
    J Antimicrob Chemother; 2001 May; 47(5):671-4. PubMed ID: 11328782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial properties of some cyclic organobismuth(III) compounds.
    Kotani T; Nagai D; Asahi K; Suzuki H; Yamao F; Kataoka N; Yagura T
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2729-34. PubMed ID: 15980343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci.
    Kurazono M; Ida T; Yamada K; Hirai Y; Maruyama T; Shitara E; Yonezawa M
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2831-7. PubMed ID: 15273088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
    Pillar CM; Aranza MK; Shah D; Sahm DF
    J Antimicrob Chemother; 2008 Mar; 61(3):595-602. PubMed ID: 18218646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical modification of ravidomycin and evaluation of biological activities of its derivatives.
    Rakhit S; Eng C; Baker H; Singh K
    J Antibiot (Tokyo); 1983 Nov; 36(11):1490-4. PubMed ID: 6654759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro and in-vivo activities of DW-116, a new fluoroquinolone.
    Choi KH; Hong JS; Kim SK; Lee DK; Yoon SJ; Choi EC
    J Antimicrob Chemother; 1997 Apr; 39(4):509-14. PubMed ID: 9145824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new antitumor antibiotic, chromoxymycin. II. Production, isolation, characterization and antitumor activity.
    Hori Y; Hino M; Kawai Y; Kiyoto S; Terano H; Kohsaka M; Aoki H; Hashimoto M; Imanaka H
    J Antibiot (Tokyo); 1986 Jan; 39(1):12-6. PubMed ID: 3949625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of some heterocyclic derivatives.
    Alsaleh FS; Gamal el-Din AY; Kandeel EM
    Microbios; 1995; 82(331):87-93. PubMed ID: 7609663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility testing of macrolide and lincosamide antibiotics according to DIN guidelines. Deutsches Institut für Normung.
    Schmalreck AF; Kottmann I; Reiser A; Ruffer U; Schlenk R; Vanca E; Wildfeuer A
    J Antimicrob Chemother; 1997 Aug; 40(2):179-87. PubMed ID: 9301982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of antimicrobial resistance].
    Hori S; Hiramatsu K
    Nihon Rinsho; 1994 Feb; 52(2):327-31. PubMed ID: 8126881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological screening of 7-hydroxy-4-methyl-2H-chromen-2-one, 7-hydroxy-4,5-dimethyl-2H-chromen-2-one and their some derivatives.
    Khan KM; Saify ZS; Begum S; Noor F; Khan MZ; Hayat S; Choudhary MI; Perveen S; Atta-Ur-Rahman ; Zia-Ullah
    Nat Prod Res; 2003 Apr; 17(2):115-25. PubMed ID: 12713124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.